Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011;66(6):985-9.
doi: 10.1590/s1807-59322011000600011.

Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease

Luciano Maurício de Abreu Filho  1 , Antonio Artur da Cruz Forte, Marcos Kiyoshi Sumita, Desidério Favarato, George Cesar Ximenes Meireles
Affiliations
Randomized Controlled Trial

Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease

Luciano Maurício de Abreu Filho et al. Clinics (Sao Paulo). 2011.

Abstract

Background: In Brazil, despite the recommendations of the Brazilian Society of Hemodynamics and Interventional Cardiology, the National Health System has not yet approved the use of drug-eluting stents. In percutaneous coronary interventions performed in the public and part of the private health care system, bare metal stents are used as the only option. Therefore, new information on bare metal stents is of great importance. The primary endpoint was to evaluate the influence of the alloy and the profile of coronary stents on late loss and restenosis rates 6 months after implantation in patients with multivessel coronary disease.

Methods: Single center, randomized and prospective study comparison of cobalt-chromium versus stainless steel stent implantation in 187 patients with multivessel coronary disease. At least one cobalt-chromium and one stainless steel stent were implanted per patient.

Results: Mean age of patients was 59.5 + 10.1 years with a prevalence of males (66.3%) and patients with acute coronary syndrome (56%). Baseline clinical characteristics were similar with hypertension in 146 (78%), dyslipidemia in 85 (45.5%) and diabetes in 68 (36.4%). Two hundred and twenty-nine cobalt-chromium and 284 stainless steel stents were implanted. Angiographic variables showed no statistically significant difference. Angiographic follow-up to 6 months after implantation showed similar late loss and restenosis rates.

Conclusion: The use of two different alloys, stainless steel and cobalt-chrome stents, in the same patient and in the same vessel produced similar 6-month restenosis and late loss rates.

PubMed Disclaimer

References

    1. Mansur A de P, Favarato D, Avakian SD, Ramires JA. Trends in ischemic heart disease and stroke death ratios in Brazilian women and men. Clinics. 2010;65:1143–7. 10.1590/S1807-59322010001100016 - DOI - PMC - PubMed
    1. Bampi AB, Rochitte CE, Favarato D, Lemos PA, da Luz PL. Comparison of non-invasive methods for the detection of coronary atherosclerosis. Clinics. 2009;64:675–82. 10.1590/S1807-59322009000700012 - DOI - PMC - PubMed
    1. Lima VC, Matos LAP, Caramori PRA, Perin MA, Mangione JM, Machado BM, et al. Consenso de Especialistas (SBC/SBHCI) Sobre o Uso de Stents Farmacológicos. Recomendações da Sociedade Brasileira Cardiologia/Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista ao Sistema Único de Saúde. Arq Bras Cardiol. 2006;87:e162–7. 10.1590/S0066-782X2006001700037 - DOI - PubMed
    1. Stents farmacológicos e stents metálicos no tratamento da doença arterial coronariana. Boletim Brasileiro de Avaliação de Tecnologia em Saúde (BRATS), June 2009. Available at www.anvisa.gov.br/divulga/newsletter/brats/2009/BRATS8.pdf (accessed 22 February 2009).
    1. Chamié D, Abizaid A. Stent cronus: chegou o momento de adotarmos um stent nacional. Rev Bras Cardiol Invas. 2009;17:300–4.

Publication types